Employees
Employed at Rhenman & Partners since 2023. Teresa has worked in different roles within the financial industry since 2011 and has, among others, served as CEO for Swedsec and acting CEO for Första AP-fonden. Education: Law degrees from Humboldt University Berlin, King’s College London and Stockholm University.
Employed at Rhenman & Partners since 2008. Over 25 years of experience in portfolio management. Education: Biochemist, Royal Institute of Technology, B.Sc., Stockholm School of Economics.
Employed at Rhenman & Partners since 2023. 20 years of experience in the financial and fund sector. Education: B.Sc. in Economics, Jönköping International Business School.
Employed at Rhenman & Partners since 2017. Education: Business Administration, Finance, B.Sc., Stockholm Business School.
Employed at Rhenman & Partners since 2020. Education: B.Sc. Business & Economics, Stockholm School of Economics.
Employed at Rhenman & Partners since 2023. 15 years of experience in medical positions within the life science industry. Education: M.Sc. Biomedicine and a PhD, Karolinska Institute.
Employed at Rhenman & Partners since 2024. 18 years of experience from the financial service industry in Sweden, US and UK focusing on the global life science industry. Education: MSc. Biochemistry, Lund University; PhD Medicine, Karolinska Institute; and MBA Finance, Hawaii Pacific University
Employed at Rhenman & Partners since 2022. 10 years of experience in wealth management. Education: M.Sc. in Business Administration, Finance, Linköping University
Employed at Rhenman & Partners since 2024. Tom has 20 years of experience from asset management and sales roles, most recently from Brummer Partners. Education: M.Sc. Business and Economics, School of Business and Economics, University of Gothenburg
Employed at Rhenman & Partners since 2024. Mattias has 25 years of experience from the financial industry, including roles at Carnegie, Goldman Sachs and SEB. Education: Executive MBA, Stockholm School of Economics.
Employed at Rhenman & Partners since 2021. 15 years of experience from marketing and communication roles within the financial sector. Education: M.Sc. in Business and Economics, Karlstad University.
Employed at Rhenman & Partners since 2013. Camilla has worked within the financial industry as an adminitrator/assistent since 2008.
Employed at Rhenman & Partners since 2025. Five years of experience within the financial sector. Education: M.Sc. Fluid mechanics, Royal Institute of Technology
Board of Directors
Professor emeritus of Immunology, Karolinska Institutet. Former president of Karolinska Institutet, head of the Infectious Disease Institute, the State Bacteriological Laboratory and chair of Karolinska Institutet’s Nobel Committee. Member of the Royal Academy of Sciences and the Royal Swedish Academy of Sciences IVA. Active board assignments: Sarepta Therapeutics, Raysearch Laboratories, Wigzellproduktion AB, Segulah Medical Acceleration. Total number of active board assignments: 4
Birgitta has an M.Sc. in Chemistry/Biotechnology from the Royal Institute of Technology (KTH) and an MBA from Harvard Business School. She is a board member at Asker Healthcare Group, Pandora A/S, Bure Equity AB and Bentley Endovascular and she is the Chairman of the Board of Industrifonden. Previously Birgitta has been the CEO of Memira Group, COO at Telefos, McKinsey Associate and Product Manager at Gambro. She has also previously been a board member of Elekta AB.
Total number of active board assignments: 5
Lars has a Master of Science degree in Business and Economics from Uppsala University. He is a Swedish industry veteran, and previous roles include CEO of FAM AB, CFO Alfred Berg and CFO Investor AB. Apart from being on Rhenman & Partners’ board, Lars is the Chairman of the board in AMF Tjänstepension, member of the board at the Stockholm Chamber of Commerce (Vice-Chairman), Rederi AB Gotland and Wall to Wall Group. Previous directorships include board member at Nasdaq Group Inc, SKF, Grand Hôtel, FAM, IPCO AB and Höganäs AB.
Total number of active board assignments: 8
Dan has a law degree from Uppsala University, has completed training of judges and held the role of Associate Judge (Hovrättsassessor) in Svea Court of Appeal. He has a long background of legal counsel roles within the financial sector. Previous roles include Legal Counsel Skandia Insurance Company, Deputy General Counsel and deputy head of the Legal & Security Department of Sweden Post, General Counsel Postgirot Bank AB as well as Group General Counsel at Carnegie Investment Bank, Lawyer. Active board assignments: The Hans Wigzell Research Foundation, Hoflund Juridik AB.
Total number of active board assignments: 3
Biochemist, Royal Institute of Technology and M.Sc., School of Business. Founder and Managing Director, Rhenman & Partners. Former Founder & CIO, Carnegie Healthcare Funds, Carnegie Investment Bank. Managing Director, Portfolio Manager, SG Cowen, Boston. Portfolio manager, SEB Pharmaceutical Fund. Head of Analysis, Hagströmer & Qviberg.
Total number of active board assignments: 2